ImportRefusal LogoImportRefusal

Violation Code: 75

FDA Violation

Charge Code: UNAPPROVED

74,390
Total Refusals
26301
Affected Firms
1/22/2026
Latest Case
10/3/2001
First Case

Violation Details

Violation Code (ASC ID)
75
Charge Code
UNAPPROVED
Description
The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).
Legal Section
505(a), 801(a)(3); UNAPPROVED NEW DRUG

Most Affected Firms

#Firm NameLocationCases
1Wicks Pharmaceuticals Pvt LtdBangalore, INDIA576
2DREAM COSMETICSAbigian, IVORY COAS415
3Laboratorios PiSA, S.A. de C.V (Planta Tlajomulco)Tlajomulco De Zuniga, MEXICO379
4Nouvelle Parfumeria GandourAbidjan 01, IVORY COAS311
5NOVO NORDISKMississauga, CANADA197
6Sanofi-Aventis US LLCSaint Louis, UNITED STA196
7A.H. GEIGERLorrach, GERMANY177
8Novo Nordisk A/SBagsvard, DENMARK172
9Chemo S.A. Lugano BranchLugano, SWITZERLAN171
10PLANTAS MEDICINALES DE MEXICODELEGACION XOCHIMILCO C.P, MEXICO169
11PATANJALI AYURVED LIMITEDHaridwar, INDIA169
12NATURE REPUBLIC CO., LTD.Seoul, SOUTH KORE154
13Wendt-Chemie Vertriebsges Mbh & Co.Hamburg, GERMANY151
14Productos Maver, S.A. de C.V.Tlaquepaque, MEXICO146
15Merck, S.A. de C.V.Naucalpan De Juarez, MEXICO137
16SKYLINE HANDELS GMBHVienna, AUSTRIA135
17Apotex Inc.North York, CANADA128
18OMEGA NUTRITIONHidalgo Del Parral, MEXICO127
19TerravitaBrampton, CANADA119
20Biologische Heilmittel Heel GmbhBaden-Baden, GERMANY118

Recent Import Refusals

DateProductFirm
1/22/2026
OTHER SKIN CARE PREPARATIONS, N.E.C.
53LD99
Cosmax IncSOUTH KORE
1/22/2026
ONABOTULINUMTOXINA
58PCZ05
1/22/2026
SODIUM CHLORIDE (REPLENISHER)
65RCK19
1/22/2026
EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C.
66YCY99
1/22/2026
VITAMIN, N.E.C.
54ACK99
1/22/2026
MISCELLANEOUS PATENT MEDICINES, ETC.
66VCY99
1/22/2026
ADALIMUMAB
58SCY14
1/22/2026
CAMPHOR (ANTI-PRURITIC)
62MDY01
1/22/2026
METHYLPREDNISOLONE (GLUCOCORTICOID)
64LDY44
1/22/2026
THEOPHYLLINE (BRONCHODILATOR)
63BDY30
1/22/2026
ACETAMINOPHEN (ANALGESIC)
60LDY01
1/22/2026
AZITHROMYCIN (MACAROLIDES)
56IDY76
1/22/2026
ALBUTEROL (BRONCHODILATOR)
63BDY01
1/22/2026
DAPAGLIFLOZIN (ANTI-DIABETIC)
61PDY70
1/22/2026
SITAGLIPTIN PHOSPHATE (ANTI-DIABETIC)
61PDY68

Related Violations

Other violations under the same legal section: 505(a), 801(a)(3); UNAPPROVED NEW DRUG

CodeCharge CodeCases
3874708NEWDRUG5

Frequently Asked Questions

What is FDA violation code 75?

75 is an FDA violation code that indicates: "The article is subject to refusal of admission pursuant to Section 801(a)(3) in that it appears to be a new drug within the meaning of Section 201(p) without an approved New Drug Application (NDA).". This violation is based on 505(a), 801(a)(3); UNAPPROVED NEW DRUG of the Federal Food, Drug, and Cosmetic Act.

How many import refusals have been issued for violation 75?

According to FDA Import Refusal data, there have been 74390 import refusals issued for violation code 75, affecting 26301 unique firms.

When was the most recent refusal for violation 75?

The most recent import refusal for violation 75 was on January 22, 2026.

What products are commonly refused for violation 75?

Products commonly refused under violation 75 include: OTHER SKIN CARE PREPARATIONS, N.E.C., ONABOTULINUMTOXINA, SODIUM CHLORIDE (REPLENISHER), EXHIBITS - OTHER DRUG RELATED ITEMS N.E.C., VITAMIN, N.E.C.. These products were refused entry because they did not meet FDA requirements.

What is the legal basis for FDA violation code 75?

Violation code 75 is based on 505(a), 801(a)(3); UNAPPROVED NEW DRUG of the Federal Food, Drug, and Cosmetic Act (FD&C Act). This section of the law establishes requirements that imported products must meet to be allowed entry into the United States.

Data sourced from the FDA Data Dashboard, a public database maintained by the U.S. Food and Drug Administration.